June 23, 2021 International law firm Bird & Bird has advised Korean-based Mirae Asset Capital, Celltrion and Premier Partners on Iksuda Therapeutics Limited’s (Iksuda) USD 47 million Series A financing (circa GBP 34 million).
June 15, 2021 Bird & Bird Advises Mirae Asset Capital, Celltrion And Premier Partners On Iksuda Therapeutics USD 47 Million Series A Financing.
April 20, 2021 2021 M&A Outlook For Singapore And South East Asia: Emerging Patterns In M&A Agreements.
.jpg)
